Google
DXCM — DEXCOM INC (Healthcare >> Medical Devices)
DXCM FAQ
What is DXCM's P/E ratio?
DEXCOM INC (DXCM) currently trades at a P/E ratio of 30.58.
What is DXCM's ROE?
DEXCOM INC reports a Return on Equity (ROE) of 31.47%.
What is DXCM's dividend yield?
DEXCOM INC offers a dividend yield of 0.00%.
What is DXCM's Deepscope Quality Score?
Deepscope rates DXCM's overall financial quality at 92 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy DXCM?
Deepscope's AI Timing Score for DXCM is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does DXCM belong to?
DEXCOM INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 73.45
Price
-0.68
(-0.93%)
Day Change
|
|
|---|
DXCM, the overall quality is excellent ( Quality = 92) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROA is too relatively low compare to ROE
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Quality Factors |
|
58% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 79 |
| Magic Formula Rank by ROA |
1106
|
| Magic Formula Rank by ROE |
1106
|
| Magic Formula Rank by ROIC |
1083
|
| Price | 73.45 |
| PBV / Sector |
9.62 / 5.55
|
| Earning Per Share | 2.40 |
| PE / Sector |
30.58 / 28.84
|
| PEG or PE/Growth / Sector |
0.78 / 0.72
|
| Average 1M Daily Value |
460.21 M
GREAT
|
| Average 1W Daily Value |
422.98 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
70% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-03 09:11:05 |
| Symbol | DXCM |
| Name | DEXCOM INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 385.87 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 28,454.27 / 17,899.46 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
Phone: 858 200 0200
Website: https://www.dexcom.com
Employees: 11,000
Sector: Healthcare >> Medical Devices
Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
